Apyx Medical Statistics
Total Valuation
Apyx Medical has a market cap or net worth of $129.32 million. The enterprise value is $141.33 million.
| Market Cap | 129.32M |
| Enterprise Value | 141.33M |
Important Dates
The last earnings date was Thursday, August 6, 2026, after market close.
| Earnings Date | Aug 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Apyx Medical has 42.12 million shares outstanding. The number of shares has increased by 10.48% in one year.
| Current Share Class | 42.12M |
| Shares Outstanding | 42.12M |
| Shares Change (YoY) | +10.48% |
| Shares Change (QoQ) | +0.25% |
| Owned by Insiders (%) | 13.56% |
| Owned by Institutions (%) | 37.12% |
| Float | 30.18M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.19 |
| Forward PS | 2.08 |
| PB Ratio | 12.01 |
| P/TBV Ratio | 12.01 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 2.40 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.68, with a Debt / Equity ratio of 3.57.
| Current Ratio | 5.68 |
| Quick Ratio | 4.41 |
| Debt / Equity | 3.57 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -0.63 |
Financial Efficiency
Return on equity (ROE) is -90.69% and return on invested capital (ROIC) is -4.55%.
| Return on Equity (ROE) | -90.69% |
| Return on Assets (ROA) | -3.71% |
| Return on Invested Capital (ROIC) | -4.55% |
| Return on Capital Employed (ROCE) | -6.84% |
| Weighted Average Cost of Capital (WACC) | 11.55% |
| Revenue Per Employee | $284,951 |
| Profits Per Employee | -$42,117 |
| Employee Count | 205 |
| Asset Turnover | 0.98 |
| Inventory Turnover | 2.25 |
Taxes
In the past 12 months, Apyx Medical has paid $439,000 in taxes.
| Income Tax | 439,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +35.71% in the last 52 weeks. The beta is 1.35, so Apyx Medical's price volatility has been higher than the market average.
| Beta (5Y) | 1.35 |
| 52-Week Price Change | +35.71% |
| 50-Day Moving Average | 4.17 |
| 200-Day Moving Average | 3.85 |
| Relative Strength Index (RSI) | 28.58 |
| Average Volume (20 Days) | 104,097 |
Short Selling Information
The latest short interest is 267,145, so 0.63% of the outstanding shares have been sold short.
| Short Interest | 267,145 |
| Short Previous Month | 251,668 |
| Short % of Shares Out | 0.63% |
| Short % of Float | 0.89% |
| Short Ratio (days to cover) | 2.31 |
Income Statement
In the last 12 months, Apyx Medical had revenue of $58.42 million and -$8.63 million in losses. Loss per share was -$0.20.
| Revenue | 58.42M |
| Gross Profit | 37.09M |
| Operating Income | -3.54M |
| Pretax Income | -7.97M |
| Net Income | -8.63M |
| EBITDA | -2.76M |
| EBIT | -3.54M |
| Loss Per Share | -$0.20 |
Balance Sheet
The company has $27.62 million in cash and $39.63 million in debt, with a net cash position of -$12.01 million or -$0.29 per share.
| Cash & Cash Equivalents | 27.62M |
| Total Debt | 39.63M |
| Net Cash | -12.01M |
| Net Cash Per Share | -$0.29 |
| Equity (Book Value) | 11.09M |
| Book Value Per Share | 0.25 |
| Working Capital | 43.80M |
Cash Flow
In the last 12 months, operating cash flow was -$10.13 million and capital expenditures -$920,000, giving a free cash flow of -$11.05 million.
| Operating Cash Flow | -10.13M |
| Capital Expenditures | -920,000 |
| Depreciation & Amortization | 783,000 |
| Net Borrowing | -20,000 |
| Free Cash Flow | -11.05M |
| FCF Per Share | -$0.26 |
Margins
Gross margin is 63.50%, with operating and profit margins of -6.06% and -14.78%.
| Gross Margin | 63.50% |
| Operating Margin | -6.06% |
| Pretax Margin | -13.65% |
| Profit Margin | -14.78% |
| EBITDA Margin | -4.72% |
| EBIT Margin | -6.06% |
| FCF Margin | n/a |
Dividends & Yields
Apyx Medical does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -10.48% |
| Shareholder Yield | -10.48% |
| Earnings Yield | -6.74% |
| FCF Yield | -8.63% |
Analyst Forecast
The average price target for Apyx Medical is $6.60, which is 114.98% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $6.60 |
| Price Target Difference | 114.98% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 5 |
| Revenue Growth Forecast (3Y) | 13.07% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on January 6, 1994. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jan 6, 1994 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
Apyx Medical has an Altman Z-Score of 1.07 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.07 |
| Piotroski F-Score | 3 |